Catherine Spina
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer (NCT05915442) | Catherine Spina | 2023-07-01 |
Track Catherine Spina automatically
Every clearance here is in the API, with alerts when new ones post.